As Congress provides economic support amid the coronavirus pandemic, it should also fully fund the Land and Water Conservation Fund and a backlog of National Parks maintenance work.

How bad does a national emergency have to get for President Donald Trump to use the extraordinary power he already possesses to increase production of protective equipment and ventilators in dangerously short supply, and prioritize their distribution to areas most in need?

“What happened to the soap?” That’s what many Americans may be thinking as they wander forlornly through the aisles of local grocery stores (always careful, of course, to maintain a 6-foot distance from other customers). Fresh food may be abundant, but the necessities of a disease quarantine — hand soap, sanitizer, toilet paper and so on — are increasingly hard to find. For some items, such as peanut butter, this isn’t much of a problem. But for soap, hoarding could set back the country’s ability to suppress the coronavirus by making it harder for people to clean their hands — which medical professionals say is important to prevent the disease from spreading.

The COVID-19 coronavirus crisis has brought out the compassion and good-heartedness of many Americans. Unfortunately, there is no crisis that scammers will not seek to exploit.

As much as the nation’s elected leaders from the White House to statehouses have found themselves at the vanguard of health care policy in recent days, taking dramatic actions to close schools, churches and businesses to lessen the severity of the coronavirus outbreak, the day is swiftly coming for equally decisive action to protect the nation’s economy from the worst of a looming recession.

The intensifying drumbeat of coronavirus-related restrictions and shutdowns has drawn outrage from some conservatives, who argue that the government is driving the U.S. economy into a ditch and, by overreacting, pushing us unnecessarily into recession. Some even contend that this whole virus thing is a plot by liberals to prevent President Trump from being reelected in November.

The Trump administration’s outreach to insulin manufacturers and health insurers to reduce the price of insulin for more than 3.3 million Medicare recipients is a terrific first step in addressing the rising cost of prescription drugs.